E
Eva S. Schernhammer
Researcher at Medical University of Vienna
Publications - 298
Citations - 22977
Eva S. Schernhammer is an academic researcher from Medical University of Vienna. The author has contributed to research in topics: Breast cancer & Cancer. The author has an hindex of 68, co-authored 265 publications receiving 19787 citations. Previous affiliations of Eva S. Schernhammer include University of Vienna & Duke University.
Papers
More filters
Journal Article
[Drug interactions between interferon alpha 2b and 5-fluorouracil during continuous intravenous 5FU infusion].
TL;DR: There might exist a linear correlation between the order of magnitude of the 5FU serum concentrations and its pharmacokinetic parameters on day 1, 3 and 5 and the administration of IFN, because a close correlation ranging from R = 0.972 to R =0.999 have been found in regression analysis.
Journal ArticleDOI
Risk thresholds for alcohol consumption.
Proceedings ArticleDOI
Abstract 2178: Rotating night shift work and cancer mortality in the nurses' health study
TL;DR: Women working rotating night-shifts for more than 15 years had modestly increased colorectal and lungcancer mortality but the increase in lung cancer mortality was largely limited to current smokers and it is possible that these observations remain residually confounded by smoking.
Journal ArticleDOI
Solar activity and urinary melatonin levels in the US-based Nurses’ Health Study, Nurses’ Health Study II, and the Growing Up Today Study
C. Hu,Susanne Strohmaier,Petros Koutrakis,C. Z. Zilli Vieira,Trang VoPham,J.C. Chavarro,Francine Laden,Eva S. Schernhammer,Jaime E. Hart +8 more
TL;DR: In this article , the authors evaluated the associations between urinary melatonin (6-sulfatoxymelatonin) and solar activity exposures (sunspot number, Kp index, and interplanetary magnetic field strength (IMF)) in the prospective US-based Nurses' Health Study (NHS), Nurses’ Health Study II, and Growing Up Today Study (GUTS) cohorts.
Journal ArticleDOI
The Association of Time of Day of ChAdOx1 nCoV-19 Vaccine Administration With SARS-CoV-2 Anti-Spike IgG Antibody Levels: An Exploratory Observational Study
Astrid Erber,Angelika Wagner,Marianna Karachaliou,Maren Jeleff,Polyxeni Kalafatis,Manolis Kogevinas,Beata Peplonska,Isabel Santonja,Eva S. Schernhammer,Hannes Stockinger,Kurt Straif,Ursula Wiedermann,Thomas Waldhör,Kyriaki Papantoniou +13 more
TL;DR: In this paper , the authors investigated the effect of time of day of administration of a COVID-19 vector vaccine, ChAdOx1 nCoV-19 (AstraZeneca), on SARS-CoV2 anti-spike S1 immunoglobulin (IgG) levels.